Resources

Commissioner

NHS England, CCGs and local authorities are all responsible for commissioning different parts of hepatitis C testing, treatment and care.  Find here tools, templates and other relevant documents to assist commissioners with their responsibilities to ensure hepatitis C patients are diagnosed and receive high quality care.

Showing 21 to 30 of 210 resources

  • Hepatitis C in the UK 2016 report
    This report, published by Public Health England, summarises the scale of the hepatitis C issue in the UK in 2015, in order to help support focused action in UK countries via their national action plans, and in order to eliminate hepatitis C as a major public health threat by 2030. It provides a host of relevant statistics and information related to prevalence, diagnosis, testing and treatment.
    UK Aug 2016 Reports & Research PDF
  • HCV Action good practice case study: Outreach service in Newcastle
    This HCV Action good practice case study looks at an outreach service that has been developed in Newcastle. Based at Freeman Hospital, Newcastle, the service delivers three outreach centres in locations across the north east region. Prior to the outreach service, hospital attendance at new hepatitis C patient appointments was less than 50%. The service has resulted in attendance rates of 75%, an increase in the numbers of people being treated, and comparable Sustainable Virological Response (SVR) rates as hospital-based treatment.

    North East, UK, England Jul 2016 Case study PDF
  • Summary report: Hepatitis C good practice roadshow, Newcastle
    This report provides a summary of the good practice hepatitis C roadshow held by HCV Action and Public Health England in Newcastle on 17th May 2016. The roadshow was aimed at sharing good practice around hepatitis C and instigating local action to address the virus. The report includes summaries of the talks and workshops held on the day, as well as suggested next steps to be taken in order to tackle hepatitis C more effectively in Newcastle and the wider north east area.
    North East, UK, England Jun 2016 Reports & Research PDF
  • HCV Action and PHE hepatitis C roadshow in Newcastle: Presentations
    On 17th May 2016, HCV Action and Public Health England (PHE) staged a hepatitis C good practice roadshow in Newcastle. The event was designed to showcase and share best practice in the prevention, diagnosis, testing and treatment of hepatitis C, and identify specific issues and potential solutions for tackling hepatitis C in Newcastle and the wider north east region.
    North East, UK, England Jun 2016 Other, Strategy & Planning PDF
  • HCV Action good practice case study: Waverley Care Self Management Programme
    This good practice case study looks at the Waverley Care Self Management Programme. The programme involves the delivery of workshops to people with hepatitis C, which focus on issues such as self-identity, confidence, self-esteem, goal setting and problem solving, with the aim of supporting people with hepatitis C to make informed choices regarding their lifestyle choices and improve the knowledge that they have of their condition.

    The case study explains details why the programme was established, how it works, and the outcomes that it has achieved.
    UK, Scotland Apr 2016 Case study PDF
  • HCV Action good practice case study: Positive Help support services
    This good practice case study looks at the support services offered to people with hepatitis C in the Lothians by Positive Help. These services include a transport service which allows service users to attend appointments and stay engaged in the care pathway, as well as a service providing domestic help in service users' homes.

    This case study details why the services were established, how they work, and the outcomes that they have achieved.
    UK, Scotland Apr 2016 Case study PDF
  • New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England
    This article provides analysis of the estimated impact of new treatment for hepatitis C on both the prevention of transmission of the virus, and on preventing hepatitis C-related liver disease.

    It concludes that focusing treatment solely on people with cirrhosis is not a tenable long-term strategy if continued reductions in new cases of end stage liver disease and hepatocellular carcinoma, as well as reductions in transmission are to be achieved. It also finds that treatment of other groups will need to follow quickly if these reductions are to be achieved.
    England Apr 2016 Reports & Research PDF
  • Hepatitis C ODNs and Clinical Leads
    Operational Delivery Networks (ODNs) are the new structures through which hepatitis C treatment in England is being delivered. The Network involves regional centres which manage treatment decisions and prescribing, and which have a dispersed treatment model which aims to support partnership working and access for local patients.

    This graphic details each ODN across England, along with the named ODN Clinical Lead for each.
    England Apr 2016 Other, Strategy & Planning PDF
  • Guidance: Hepatitis C prevention, diagnosis and treatment in prisons in England
    This document, published by The Hepatitis C Trust after convening an expert group of prison healthcare commissioners and practitioners, provides commissioners and prison healthcare teams with practical guidance regarding the implementation of opt-out BBV testing and related hepatitis C care pathways, which can be adapted and used by any prison that needs to develop, revise or update their services.

    UK, England Mar 2016 Reports & Research, Tools & Templates, Strategy & Planning PDF
  • The blood borne virus opt-out testing policy for prisons in England: An analysis of need towards full implementation
    In recognition of the exceptionally high prevalence of blood borne viruses (BBVs), in particular hepatitis C, amongst people in prisons and previously very low rates of testing, in October 2013 Public Health England (PHE), NHS England and the National Offender Management Service (NOMS) agreed to introduce opt-out testing for hepatitis B, hepatitis C and HIV across the prison estate by 2016/17.
    UK, England Mar 2016 Reports & Research, Strategy & Planning PDF

Pages